AKT1 and prostate carcinoma: Suppression of GSK-3 by treatment with the GSK-3 inhibitor SB415286 suppressed motility, proliferation and colony formation in PC3 prostate cancer cells which express large amounts of activated Akt due to PTEN deletion.